- ¥55bn
- ¥43bn
- ¥54bn
- 92
- 75
- 75
- 95
Annual balance sheet for Anest Iwata, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 13,200 | 14,320 | 14,512 | 16,931 | 21,336 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,399 | 7,742 | 8,724 | 9,427 | 9,877 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 28,893 | 34,326 | 36,773 | 40,571 | 45,229 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11,355 | 11,449 | 12,461 | 13,715 | 15,095 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 49,459 | 55,819 | 60,137 | 66,144 | 69,202 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,607 | 11,616 | 11,720 | 12,789 | 12,161 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 17,216 | 20,195 | 20,111 | 21,985 | 22,348 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 32,243 | 35,623 | 40,026 | 44,159 | 46,854 |
Total Liabilities & Shareholders' Equity | 49,459 | 55,819 | 60,137 | 66,144 | 69,202 |
Total Common Shares Outstanding |